200 related articles for article (PubMed ID: 8833766)
1. Role of platelet-activating factor and thromboxane A2 in radical production during ischemia and reperfusion of the rat brain.
Matsuo Y; Kihara T; Ikeda M; Ninomiya M; Onodera H; Kogure K
Brain Res; 1996 Feb; 709(2):296-302. PubMed ID: 8833766
[TBL] [Abstract][Full Text] [Related]
2. Role of neutrophils in radical production during ischemia and reperfusion of the rat brain: effect of neutrophil depletion on extracellular ascorbyl radical formation.
Matsuo Y; Kihara T; Ikeda M; Ninomiya M; Onodera H; Kogure K
J Cereb Blood Flow Metab; 1995 Nov; 15(6):941-7. PubMed ID: 7593354
[TBL] [Abstract][Full Text] [Related]
3. Role of thromboxane A2 and platelet-activating factor in allergic bronchoconstriction in guinea pig airway in vivo.
Saito M; Fujimura M; Ogawa H; Matsuda T
J Lipid Mediat Cell Signal; 1995 Jan; 11(1):1-12. PubMed ID: 7728413
[TBL] [Abstract][Full Text] [Related]
4. Effect of a novel thromboxane A2 receptor antagonist, S-1452, on postischemic brain injury in rats.
Matsuo Y; Izumiyama M; Onodera H; Kurosawa A; Kogure K
Stroke; 1993 Dec; 24(12):2059-64; discussion 2064-5. PubMed ID: 8248988
[TBL] [Abstract][Full Text] [Related]
5. Roles of platelet-activating factor, thromboxane A2, ADP and thrombin in thrombogenesis in the guinea pig.
Hirata Y; Takiguchi Y; Wada K; Matsuno H; Umemura K; Uematsu T; Nakashima M
Eur J Pharmacol; 1993 Feb; 231(3):421-5. PubMed ID: 8449234
[TBL] [Abstract][Full Text] [Related]
6. Role of thromboxane A2 and platelet activating factor in early haemodynamic response to lipopolysaccharide in rats.
Bocheński J; Chłopicki S; Gryglewski RJ
J Physiol Pharmacol; 1999 Jun; 50(2):287-97. PubMed ID: 10424723
[TBL] [Abstract][Full Text] [Related]
7. Interactions of constitutive nitric oxide with PAF and thromboxane on rat intestinal vascular integrity in acute endotoxaemia.
László F; Whittle BJ; Moncada S
Br J Pharmacol; 1994 Dec; 113(4):1131-6. PubMed ID: 7889265
[TBL] [Abstract][Full Text] [Related]
8. Direct detection of ascorbyl radical in experimental brain injury: microdialysis and an electron spin resonance spectroscopic study.
Kihara T; Sakata S; Ikeda M
J Neurochem; 1995 Jul; 65(1):282-6. PubMed ID: 7790872
[TBL] [Abstract][Full Text] [Related]
9. Involvement of platelet activating factor and thromboxane A2 in the renal response to unilateral ureteral obstruction.
Felsen D; Loo MH; Marion DN; Vaughan ED
J Urol; 1990 Jul; 144(1):141-5. PubMed ID: 2141654
[TBL] [Abstract][Full Text] [Related]
10. Platelet-activating factor increases vascular resistance in rat hindquarters by thromboxane A2.
Rizzo A; Taylor AE; Townsley MI; Logsdon P; Khimenko PL; Fletcher JR
Am J Physiol; 1995 May; 268(5 Pt 2):H1954-8. PubMed ID: 7771545
[TBL] [Abstract][Full Text] [Related]
11. PAF effects on eicosanoid release in neonatal rat cardiomyocytes.
Becker K; Heinroth-Hoffmann I; Giessler C; Pönicke K; Brodde OE
Prostaglandins Leukot Essent Fatty Acids; 1995 Sep; 53(3):197-200. PubMed ID: 7480082
[TBL] [Abstract][Full Text] [Related]
12. Role of platelet-activating factor (PAF) in oxygen radical-induced cardiac dysfunction.
Alloatti G; Montrucchio G; Camussi G
J Pharmacol Exp Ther; 1994 May; 269(2):766-71. PubMed ID: 8182544
[TBL] [Abstract][Full Text] [Related]
13. Endothelin-1-induced myocardial ischaemia and oedema in the rat: involvement of the ETA receptor, platelet-activating factor and thromboxane A2.
Filep JG; Fournier A; Földes-Filep E
Br J Pharmacol; 1994 Jul; 112(3):963-71. PubMed ID: 7921626
[TBL] [Abstract][Full Text] [Related]
14. Role of platelet-activating factor in skeletal muscle ischemia-reperfusion injury.
Silver D; Dhar A; Slocum M; Adams JG; Shukla S
Adv Exp Med Biol; 1996; 416():217-21. PubMed ID: 9131151
[TBL] [Abstract][Full Text] [Related]
15. Increased prostaglandin I2 and thromboxane A2 production by rat dental pulp after intravenous administration of endotoxin.
Hirafuji M; Shinoda H
Arch Oral Biol; 1994 Nov; 39(11):995-1000. PubMed ID: 7695514
[TBL] [Abstract][Full Text] [Related]
16. Reduction of hypoxic-ischemic brain swelling in the neonatal rat with PAF antagonist WEB 2170: lack of long-term protection.
Viswanath M; Palmer C; Roberts RL
Pediatr Res; 2000 Jul; 48(1):109-13. PubMed ID: 10879808
[TBL] [Abstract][Full Text] [Related]
17. Hyperglycemic damage to mitochondrial membranes during cerebral ischemia: amelioration by platelet-activating factor antagonist BN 50739.
Kintner DB; Fitzpatrick JH; Gilboe DD
J Neurochem; 1997 Sep; 69(3):1219-27. PubMed ID: 9282946
[TBL] [Abstract][Full Text] [Related]
18. Involvement of platelet-activating factor (PAF) in endotoxin- or ischaemia-induced intestinal hyperpermeability in the rat.
Defaux JP; Thonier F; Baroggi N; Etienne A; Braquet P
J Lipid Mediat; 1993 May; 7(1):11-21. PubMed ID: 8358021
[TBL] [Abstract][Full Text] [Related]
19. Platelet-activating factor and arachidonic acid metabolites mediate tumor necrosis factor and eicosanoid kinetics and cardiopulmonary dysfunction during bacteremic shock.
Quinn JV; Slotman GJ
Crit Care Med; 1999 Nov; 27(11):2485-94. PubMed ID: 10579269
[TBL] [Abstract][Full Text] [Related]
20. Cardioprotective actions of the specific thromboxane receptor antagonist (+)-S145Na following coronary occlusion and reperfusion in the rat.
Tsao PS; Lefer AM
Res Commun Chem Pathol Pharmacol; 1990 Nov; 70(2):205-11. PubMed ID: 2148980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
